SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-012189
Filing Date
2021-05-14
Accepted
2021-05-14 08:00:35
Documents
46
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cbli20210331_10q.htm 10-Q 557307
2 EXHIBIT 31.1 ex_239991.htm EX-31.1 13767
3 EXHIBIT 32.1 ex_239992.htm EX-32.1 7511
  Complete submission text file 0001437749-21-012189.txt   2994132

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cbli-20210331.xml EX-101.INS 509296
5 XBRL TAXONOMY EXTENSION SCHEMA cbli-20210331.xsd EX-101.SCH 36930
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbli-20210331_cal.xml EX-101.CAL 24520
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbli-20210331_def.xml EX-101.DEF 225172
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbli-20210331_lab.xml EX-101.LAB 231298
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbli-20210331_pre.xml EX-101.PRE 247567
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32954 | Film No.: 21921983
SIC: 2834 Pharmaceutical Preparations